RxDoctor Payments DataLook up a doctor →

Michael Cuttica, MD

Critical Care Medicine · Chicago, ILNPI 1932224441

Payments from drug & device makers

$764,948in general payments, 2019–2025

Across 546 payments — averaging $1401.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • United Therapeutics Corporation$214K
  • Insmed, Inc.$178K
  • Actelion Pharmaceuticals US, Inc.$157K
  • Janssen Research & Development, LLC$104K
  • Bayer$100K
  • Merck$12K
  • plus $315 from 8 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$764,948 in reported general payments places this provider in the 95th percentile of 281 critical care medicine providers in Illinois.

See all critical care medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$120,436
Medicare patients
306
Services billed
781

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →